Inventor · disambiguated record
Bonnie Davis
Also filed as: DAVIS BONNIE · DAVIS BONNIE M
10 granted patents·4 pending applications·231 citations·filing 1986–2016
90Inventor score
Top patents by PatentIndex Score
14 records- 0193US4663318AMethod of treating Alzheimer's diseaseBONNIE DAVIS·Filed 1986·Granted May 5, 1987·102 cites·7 claims
- 0286US6569848B1Compounds for the treatment of alzheimer's diseaseBONNIE DAVIS·Filed 2000·Granted May 27, 2003·14 cites·24 claims
- 0383US6150354ACompounds for the treatment of Alzheimer's diseaseBONNIE DAVIS·Filed 1993·Granted Nov 21, 2000·48 cites·39 claims
- 0482US11219627B2Clearance of amyloid betaSYNAPTEC DEV LLC·Filed 2015·Granted Jan 11, 2022·3 cites·47 claims
- 0575US6670356B2Analogs of galanthamine and lycoramine as modulators of nicotinic receptorsFiled 2000·Granted Dec 30, 2003·9 cites·11 claims
- 0673US6319919B1Galanthamine derivatives for treatment of alzheimer's diseaseBONNIE DAVIS·Filed 1995·Granted Nov 20, 2001·30 cites·67 claims
- 0770US6268358B1Compounds for the treatment of Alzheimer's diseaseBONNIE DAVIS·Filed 1995·Granted Jul 31, 2001·10 cites·26 claims
- 0861US2004023984A1Compounds for the treatment of alzheimer's diseaseBONNIE DAVIS·Filed 2003·Application pending·0 cites
- 0958US5585375AMethod for alleviating jet lagFiled 1994·Granted Dec 17, 1996·13 cites·7 claims
- 1040US10561665B2Treatment of autismSYNAPTEC DEV LLC·Filed 2015·Granted Feb 18, 2020·0 cites·11 claims
- 1139US2003162770A1Use of modulators of nicotinic receptors for treatment of cognitive dysfunctionFiled 2002·Application pending·0 cites
- 1238US2018200259A1GALANTAMINE CLEARANCE OF AMYLOID ßSYNAPTEC DEV LLC·Filed 2016·Application pending·0 cites
- 1330US7939522B1Dosage formulations for acetylcholinesterase inhibitorsDAVIS BONNIE M·Filed 1999·Granted May 10, 2011·2 cites·32 claims
- 1425US2017182058A1Treatment of rett syndromeEMICIPI LLC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Bonnie Davis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →